Cat. No.: X23-12-YM486

Silodosin

Synonym: 160970-54-7; KAD 3213

  • CAS Number: 160970-54-7
  • PubChem CID: 5312125
Product Size
5 mg; 10 mg; 50 mg; 100 mg
Price
Datasheet
MSDS
Properties
Description
Silodosin (rapaflo), soluble in DMSO and ethanol and insoluble in water, inhibits the signaling pathway between G-protein-coupled receptors (GPCRs) and G proteins. It targets α1-adrenergic receptor.
Molecular Weight
495.5
Molecular Formula
C25H32F3N3O4
Targets
α1-Adrenergic receptor
Form
Lyophilized powder
Purity
>98%
Solubility
DMSO: 97 mg/mL (195.74 mM); Water: insoluble; Ethanol: 97 mg/mL (195.74 mM)
Stability
The product is stable for three years when stored at the recommended temperature in lyophilized powder.
Applications
Silodosin (rapaflo) can be used for its effect on selectively blocking alpha-1 adrenergic receptors in the prostate gland, leading to relaxation of smooth muscle tissue in the prostate and the bladder neck, which helps improve urinary flow and reduce symptoms of obstruction.
Storage
Store at -20℃, and keep desiccated.
Related Products

Thanksgiving 2024

About Us

CD BioGlyco is a world-class biotechnology company with offices in many countries. Our products and services provide a viable option to what is otherwise available.

Contact Us

Copyright © CD BioGlyco. All rights reserved.
0